2016
DOI: 10.1016/j.celrep.2016.03.049
|View full text |Cite
|
Sign up to set email alerts
|

Cdk1 Phosphorylates SPAT-1/Bora to Promote Plk1 Activation in C. elegans and Human Cells

Abstract: The conserved Bora protein is a Plk1 activator, essential for checkpoint recovery after DNA damage in human cells. Here, we show that Bora interacts with Cyclin B and is phosphorylated by Cyclin B/Cdk1 at several sites. The first 225 amino acids of Bora, which contain two Cyclin binding sites and three conserved phosphorylated residues, are sufficient to promote Plk1 phosphorylation by Aurora A in vitro. Mutating the Cyclin binding sites or the three conserved phosphorylation sites abrogates the ability of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
55
1
1

Year Published

2016
2016
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 45 publications
(63 citation statements)
references
References 37 publications
6
55
1
1
Order By: Relevance
“…CENP-A is phosphorylated during early mitosis by Cdk1 and this phosphorylation is required for mitotic exit (Yu et al, 2015). Cdk1 also phosphorylates SPAT-1/Bora protein, a PLK1 activator, and regulates mitotic entry (Thomas et al, 2016). Thus Cdk activity is essential for proper cell cycle progression by regulating CENP-A and PLK1 activity.…”
Section: Discussionmentioning
confidence: 99%
“…CENP-A is phosphorylated during early mitosis by Cdk1 and this phosphorylation is required for mitotic exit (Yu et al, 2015). Cdk1 also phosphorylates SPAT-1/Bora protein, a PLK1 activator, and regulates mitotic entry (Thomas et al, 2016). Thus Cdk activity is essential for proper cell cycle progression by regulating CENP-A and PLK1 activity.…”
Section: Discussionmentioning
confidence: 99%
“…33 Second, several regulatory sites on Bora have been identified as well as a very prominent phospho-shift. 7, 10, 12, 25, 34, 35, 36 Therefore, it is conceivable that the phosphorylation of these sites in Bora might have a role in creating a DDR-sensitive and -reversible docking platform for Aurora A. As recruitment of Aurora A to the Plk1/Bora complex is an important step in this process, it would be interesting to investigate which of the previously identified phosphorylation sites on Bora contribute to Aurora A recruitment or recognition of the Plk1/Bora complex, to provide more insights into the mechanism and dynamics of Plk1 activation.…”
Section: Discussionmentioning
confidence: 99%
“…7, 8, 9 Phosphorylation of Plk1 at T210 by Aurora A requires binding of the co-factor Bora. 7, 9 During G2, Plk1 and Bora form a complex, which is initiated by Cdk1 activity 10, 11, 12 and leads to initial Plk1 activation in the nucleus. 13 …”
Section: Introductionmentioning
confidence: 99%
“…The CDK1 kinase domain recognizes the motif Ser–Ser/Thr–Pro/X on PLK1‐binding scaffolds and is able to phosphorylate the second amino acid, known as priming, allowing for PLK1–PBD interactions (Enserink & Kolodner, ). Some of the identified scaffolds that require this priming by CDK1 are Bora, Gravin, and cenexin (Canton et al, ; Soung et al, ; Thomas et al, ). PLK1 also has the ability to phosphorylate its own scaffold, such as PBIP1 and BubR1 at the centromeres, a mechanism commonly used to maintain its localization at kinetochores (Elowe, Hümmer, Uldschmid, Li, & Nigg, ; Lee, Oh, Kang, & Park, ).…”
Section: Function Of Plk1mentioning
confidence: 99%
“…(Choi, Liu, Sze, Dai, & Qi, ; Doxsey, Steln, Evans, Calarco, & Kirschnefi, ; Fabbro et al, ; Kolobova et al, ; Zimmerman, Sillibourne, Rosa, & Doxsey, ). The recruitment of these components require activated mitotic signaling cascades involving the mitotic kinases Aurora A, polo‐like kinases (PLKs), and cyclin‐dependent kinase 1 (CDK1) to name a few (Bruinsma et al, ; Hehnly et al, ; Lee et al, ; Sanhaji et al, ; Thomas et al, ). One kinase that seems to be at the center of this process from a single cell eukaryote to a multi‐cellular vertebrate is polo‐like kinase 1 (PLK1).…”
Section: Introductionmentioning
confidence: 99%